Altimmune, Inc.
HealthcareNASDAQ:ALT · NASDAQ Global Market
+$0.02 today
Vol 2.08M · Avg 3.81M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-62.28%
Period High
$7.71
Period Low
$2.59
Latest
$2.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$814.99M
Alto Neuroscience, Inc.
NYSE:ANRO
$753.47M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
Aura Biosciences, Inc.
NASDAQ:AURA
$411.52M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
AC Immune S.A.
NASDAQ:ACIU
$235.10M
Korro Bio, Inc.
NASDAQ:KRRO
$115.56M
enGene Holdings Inc.
NASDAQ:ENGN
$82.94M
What is the latest ALT filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does ALT have?
Intrinsic Alpha currently shows 20 recent filings for ALT.
Explore More
Continue the stock analysis
Jump to another research area for this company.